Multicenter point-prevalence evaluation of the utilization and safety of drug therapies for COVID-19

Data Availability

Data will be made available upon reasonable request from the authors. Such requests will be considered by a committee consisting of the investigators. Data will be made available pursuant to appropriate data use agreements.